LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 67 filers reported holding LARIMAR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $96,119 | -5.2% | 24,334 | -24.9% | 0.00% | – |
Q2 2023 | $101,368 | -65.2% | 32,386 | -49.7% | 0.00% | – |
Q1 2023 | $291,678 | -86.9% | 64,388 | -88.1% | 0.00% | – |
Q4 2022 | $2,233,657 | +31.6% | 540,837 | +2.0% | 0.00% | – |
Q3 2022 | $1,697,000 | +63.5% | 530,293 | +0.1% | 0.00% | – |
Q2 2022 | $1,038,000 | -51.6% | 529,808 | -0.0% | 0.00% | – |
Q1 2022 | $2,146,000 | +1589.8% | 529,984 | +4393.3% | 0.00% | – |
Q4 2021 | $127,000 | -68.6% | 11,795 | -66.4% | 0.00% | – |
Q3 2021 | $404,000 | +19.2% | 35,060 | +1.4% | 0.00% | – |
Q2 2021 | $339,000 | -11.3% | 34,588 | +32.4% | 0.00% | – |
Q1 2021 | $382,000 | -46.0% | 26,117 | -21.0% | 0.00% | – |
Q4 2020 | $708,000 | -13.2% | 33,055 | -38.6% | 0.00% | – |
Q3 2020 | $816,000 | +77.8% | 53,800 | +50.8% | 0.00% | – |
Q2 2020 | $459,000 | – | 35,688 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 3,473,366 | $14,345,001 | 3.82% |
Opaleye Management Inc. | 1,560,000 | $6,442,800 | 2.24% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,941,357 | $69,967,804 | 1.45% |
GREAT POINT PARTNERS LLC | 1,273,635 | $5,260,113 | 1.03% |
DAFNA Capital Management LLC | 473,136 | $1,954,052 | 0.55% |
COMMODORE CAPITAL LP | 750,000 | $3,098 | 0.47% |
Cheyne Capital Management (UK) LLP | 63,680 | $262,998 | 0.46% |
Atlas Venture Advisors, Inc. | 292,184 | $1,206,720 | 0.42% |
Perceptive Advisors | 2,860,000 | $11,811,800 | 0.33% |
MANGROVE PARTNERS IM, LLC | 1,292,812 | $5,339,314 | 0.30% |